Why the study?
What are the predictors of adverse events at one year in STEMI patients undergoing primary PCI?
Population
2,655 patients with ST-elevation myocardial infarction undergoing contemporary primary percutaneous coronary…
Comparison
Drug-eluting stents and assessment of clinical… vs Bare-metal stents and absence of clinical…
Design
Meta-analysis
Follow-up
one year
Authors
Loading...
Killip III/IV STEMI patients warrant closest post-PCI surveillance; reinforces its primacy in risk models and trial enrichment.
What are the predictors of adverse events at one year in STEMI patients undergoing primary PCI?
Killip class III or IV remains the strongest predictor of adverse outcomes in STEMI patients undergoing primary PCI, while DES use independently reduces the risk of TLR and definite stent thrombosis compared to BMS.
Taniwaki et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: